foxo4 dri cancer Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cells Development of a novel senolytic – FOXO4-DRI induces keloid senescent fibroblast

BPC-157 has been widely studied in preclinical models for its potential role in: Tissue regeneration research (muscle, tendon, and epithelial cells), Gastrointestinal studies, exploring protective effects on gut lining and gastric integrity, Angiogenesis and vascular modulation research, Neuroprotective and anti-inflammatory investigations, These findings support continued interest in understanding BPC-157s interaction with cellular growth and repair pathways in experimental contexts

By combining tissue repair with targeted inflammation control, this protocol represents a more advanced and comprehensive approach to gastrointestinal health

Note: All treatments are performed at our clinical facility in Houston

I built it around the brain

Mechanism of Action (Established vs